207 related articles for article (PubMed ID: 23341181)
21. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
22. Establishment of a Nomogram-Based Model for Predicting the Prognostic Value of Inflammatory Biomarkers and Preoperative D-Dimer Level in Spinal Ewing's Sarcoma Family Tumors: A Retrospective Study of 83 Patients.
Xu K; Lou Y; Sun R; Liu Y; Li B; Li J; Huang Q; Wan W; Xiao J
World Neurosurg; 2019 Jan; 121():e104-e112. PubMed ID: 30218803
[TBL] [Abstract][Full Text] [Related]
23. Identification of Common Oncogenic Genes and Pathways Both in Osteosarcoma and Ewing's Sarcoma Using Bioinformatics Analysis.
Zhang J; Huang J; Liu W; Ding L; Cheng D; Xiao H
J Immunol Res; 2022; 2022():3655908. PubMed ID: 35578666
[TBL] [Abstract][Full Text] [Related]
24. Prognostic determinants and treatment outcomes analysis of osteosarcoma and Ewing sarcoma of the spine.
Arshi A; Sharim J; Park DY; Park HY; Yazdanshenas H; Bernthal NM; Shamie AN
Spine J; 2017 May; 17(5):645-655. PubMed ID: 27856382
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical analysis of nm23 protein expression in malignant bone tumors.
Oda Y; Walter H; Radig K; Röse I; Neumann W; Roessner A
J Cancer Res Clin Oncol; 1995; 121(11):667-73. PubMed ID: 7593131
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors.
Hartman KR; Triche TJ; Kinsella TJ; Miser JS
Cancer; 1991 Jan; 67(1):163-71. PubMed ID: 1985713
[TBL] [Abstract][Full Text] [Related]
28. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
29. Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
Sotillo-Piñeiro E; Sierrasesúmaga L; Patiñno-García A
Pediatr Res; 2004 Feb; 55(2):231-5. PubMed ID: 14630995
[TBL] [Abstract][Full Text] [Related]
30. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.
Sun Z; Xu R; Li X; Ren W; Ou C; Wang Q; Zhang H; Zhang X; Ma J; Wang H; Li G
PLoS One; 2015; 10(8):e0135119. PubMed ID: 26263504
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma.
Hao H; Chen L; Huang D; Ge J; Qiu Y; Hao L
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27349943
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of factors affecting survival rate in primary bone sarcomas with extremity and pelvis involvement.
Sofulu Ö; Erol B
Acta Orthop Traumatol Turc; 2020 May; 54(3):234-244. PubMed ID: 32544060
[TBL] [Abstract][Full Text] [Related]
33. The Survival Outcomes, Prognostic Factors and Adverse Events following Systemic Chemotherapy Treatment in Bone Sarcomas: A Retrospective Observational Study from the Experience of the Cancer Referral Center in Northern Thailand.
Sirikul W; Buawangpong N; Pruksakorn D; Charoentum C; Teeyakasem P; Koonrungsesomboon N
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046640
[TBL] [Abstract][Full Text] [Related]
34. Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma.
Scotlandi K; Manara MC; Hattinger CM; Benini S; Perdichizzi S; Pasello M; Bacci G; Zanella L; Bertoni F; Picci P; Serra M
Eur J Cancer; 2005 Jun; 41(9):1349-61. PubMed ID: 15913990
[TBL] [Abstract][Full Text] [Related]
35. Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.
Haga A; Ogawara Y; Kubota D; Kitabayashi I; Murakami Y; Kondo T
Electrophoresis; 2013 Jun; 34(11):1670-8. PubMed ID: 23483572
[TBL] [Abstract][Full Text] [Related]
36. Hernias and Ewing's sarcoma family of tumours: a pooled analysis and meta-analysis.
Valery PC; Holly EA; Sleigh AC; Williams G; Kreiger N; Bain C
Lancet Oncol; 2005 Jul; 6(7):485-90. PubMed ID: 15992697
[TBL] [Abstract][Full Text] [Related]
37. The roles of metastasis-related proteins in the development of giant cell tumor of bone, osteosarcoma and Ewing's sarcoma.
Dou B; Chen T; Chu Q; Zhang G; Meng Z
Technol Health Care; 2021; 29(S1):91-101. PubMed ID: 33682749
[TBL] [Abstract][Full Text] [Related]
38. Small cell osteosarcoma of bone: an immunohistochemical study with differential diagnostic considerations.
Devaney K; Vinh TN; Sweet DE
Hum Pathol; 1993 Nov; 24(11):1211-25. PubMed ID: 7503935
[TBL] [Abstract][Full Text] [Related]
39. The Prognostic Value and Regulatory Mechanisms of microRNA-145 in Various Tumors: A Systematic Review and Meta-analysis of 50 Studies.
Xu L; Zhang Y; Tang J; Wang P; Li L; Yan X; Zheng X; Ren S; Zhang M; Xu M
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):867-881. PubMed ID: 30602498
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy in the management of osteosarcoma and Ewing's sarcoma.
Schuetze SM
J Natl Compr Canc Netw; 2007 Apr; 5(4):449-55. PubMed ID: 17442235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]